Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Learn which bonds in a ladder contribute most to tax efficiency and why. This primer covers selection criteria to help you reduce tax drag in retirement income planning.
21,965 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A February market shock erased roughly $285B in software valuations, forcing a rethink of what truly drives software ...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
Andrej Karpathy, a founding member of OpenAI, has moved to Anthropic, marking a pivotal leadership shift in the AI ra...
This deep dive analyzes what robin (rrgb) 2026 earnings could mean for Red Robin shareholders. We break down Q1 signa...
Amundi, Europe's biggest asset manager, launches a UCITS-compliant Solana fund in partnership with SPiko Finance, mar...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
Lucky To Live Here Realty is joining SERHANT.'s Long Island push, bringing a $1B+ track record to the brokerage. The ...
Lionsgate faces a shifting media world where film, TV, and streaming collide. This guide breaks down the 2026 earning...
Polymarket faced a rapid POL drain on May 22, 2026, but the team said the issue was an internal wallet breach, not a ...